Zannini Giuseppa, Tedesco Ilaria, Cozzolino Immacolata, Montella Marco, Clery Eduardo, Della Corte Carminia Maria, Morgillo Floriana, Accardo Marina, Franco Renato, Zito Marino Federica
Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania "Luigi Vanvitelli", Via L. Armanni 5, 80138 Naples, Italy.
Medical Oncology, Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Via S. Pansini 5, 80131 Naples, Italy.
Diagnostics (Basel). 2023 May 5;13(9):1637. doi: 10.3390/diagnostics13091637.
The handling of biomaterials is crucial for precision medicine in advanced-stage lung patients with only cytology or small biopsies available. The main purpose of the study was to evaluate the quantity and quality of nucleic acids extracted from mixed stained slides (MSSs), including H&E, IHC and FISH, compared to the extraction from unstained slides (USs). A series of 35 lung adenocarcinoma surgical samples was selected to set up the method and the technical approach was validated in a series of 15 small biopsies and 38 cytological samples. DNA extracted from MSSs was adequate in all samples and the Real Time PCR was successful in 30/35 surgical samples (86%), 14/15 small biopsies (93%), and 33/38 cytological samples (87%). NGS using DNA extracted from MSSs was successful in 18/35 surgical samples (51%), 11/15 small biopsies (73%), and 26/38 cytological samples (68%). RNA extracted from MSSs was unsatisfactory in all cases showing an inadequate degree of fragmentation. Our technical approach based on the recovery of stained slides could represent a strategic way forward for DNA-based biomarker testing in lung cancer cases without biomaterials. The RNA extracted from MSSs did not represent a successful approach.
对于仅能获得细胞学或小活检样本的晚期肺癌患者,生物材料的处理对精准医学至关重要。本研究的主要目的是评估从混合染色玻片(MSS)中提取的核酸的数量和质量,包括苏木精-伊红染色(H&E)、免疫组织化学染色(IHC)和荧光原位杂交(FISH),并与从未染色玻片(US)中提取的核酸进行比较。选取了35例肺腺癌手术样本建立方法,并在15例小活检样本和38例细胞学样本中验证了该技术方法。从MSS中提取的DNA在所有样本中均足够,实时聚合酶链反应(Real Time PCR)在35例手术样本中的30例(86%)、15例小活检样本中的14例(93%)以及38例细胞学样本中的33例(87%)成功。使用从MSS中提取的DNA进行的二代测序(NGS)在35例手术样本中的18例(51%)、15例小活检样本中的11例(73%)以及38例细胞学样本中的26例(68%)成功。从MSS中提取的RNA在所有情况下均不令人满意,显示出片段化程度不足。我们基于回收染色玻片的技术方法可能代表了在没有生物材料的肺癌病例中进行基于DNA的生物标志物检测的一种战略前进方向。从MSS中提取的RNA并非一种成功的方法。